IA
NVAX icon

IFG Advisory’s Novavax NVAX Stock Holding History

IFG Advisory’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.68K Buy
+1,027
New +$9.2K ﹤0.01% 1848

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

IFG Advisory's NVAX Position: Q2 2026 in Review

IFG Advisory opened a new position in Novavax (NVAX) in Q2 2026: 1,027 shares worth $9.68K. The stake represents ﹤0.01% of the portfolio and ranks #1848 among its holdings.

266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • IFG Advisory held 1,027 shares of Novavax worth $9.68K as of Q2 2026.
  • Novavax was a new IFG Advisory position in Q2 2026.
  • Novavax made up ﹤0.01% of IFG Advisory's portfolio in Q2 2026, its #1848 holding.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.